UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

B Cell Modulation Strategies in Autoimmune Diseases: New Concepts

Frontiers in immunology, 2018-04, Vol.9, p.622-622

2018

Volltextzugriff (PDF)

The DRESS Syndrome: A Literature Review

The American journal of medicine, 2011-07, Vol.124 (7), p.588-597

2011

Volltextzugriff (PDF)

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology

Frontiers in medicine, 2017-12, Vol.4, p.179-179

2017

Volltextzugriff (PDF)

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid

Scientific reports, 2019-03, Vol.9 (1), p.3525-3525, Article 3525

2019

Volltextzugriff (PDF)

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

The New England journal of medicine, 2007-08, Vol.357 (6), p.545-552

2007

Volltextzugriff (PDF)

Clinical and biological activity of rituximab in the treatment of pemphigus

Immunotherapy, 2021-01, Vol.13 (1), p.35-53

2021

Volltextzugriff (PDF)

Autoimmune Pemphigus: Latest Advances and Emerging Therapies

Frontiers in molecular biosciences, 2022-02, Vol.8, p.808536-808536

2022

Volltextzugriff (PDF)

Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus

The Journal of immunology (1950), 2009-11, Vol.183 (10), p.6207-6216

2009

Volltextzugriff (PDF)

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen

Frontiers in immunology, 2021-05, Vol.12, p.666022-666022

2021

Volltextzugriff (PDF)

Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus

Journal of Immunology, 2006-07, Vol.177 (2), p.1349-1354

2006

Volltextzugriff (PDF)

Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients

Frontiers in immunology, 2022-06, Vol.13, p.915205-915205

2022

Volltextzugriff (PDF)

B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses

Journal of investigative dermatology, 2008-12, Vol.128 (12), p.2859-2869

2008

Volltextzugriff (PDF)

Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction

Arteriosclerosis, thrombosis, and vascular biology, 2007-05, Vol.27 (5), p.1064-1071

2007

Volltextzugriff (PDF)

CD158k/KIR3DL2 Is a New Phenotypic Marker of Sezary Cells: Relevance for the Diagnosis and Follow-Up of Sezary Syndrome

Journal of investigative dermatology, 2004-03, Vol.122 (3), p.820-823

2004

Volltextzugriff (PDF)

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference

Frontiers in medicine, 2018-11, Vol.5, p.306-306

2018

Volltextzugriff (PDF)

Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice

Critical care medicine, 2009-05, Vol.37 (5), p.1724-1728

2009

Volltextzugriff (PDF)

Editorial: Skin Blistering Diseases

Frontiers in medicine, 2019, Vol.6, p.60-60

2019

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2011-08, Vol.141 (2), p.774-775

Musette, Philippe

2011

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2011, Vol.141 (2), p.774-775

Musette, Philippe

2011

Volltextzugriff (PDF)

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

The Lancet (British edition), 2017-05, Vol.389 (10083), p.2031-2040

2017

Volltextzugriff (PDF)

Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis

Current opinion in immunology, 2012-12, Vol.24 (6), p.730-735

2012

Volltextzugriff (PDF)

IL-10 produced by activated human B cells regulates CD4⁺ T-cell activation in vitro

European journal of immunology, 2010-10, Vol.40 (10), p.2686-2691

2010

Volltextzugriff (PDF)

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response

Science translational medicine, 2010-08, Vol.2 (46), p.46ra62

2010

Volltextzugriff (PDF)

Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features

JAMA dermatology (Chicago, Ill.), 2014-02, Vol.150 (2), p.206

2014

Volltextzugriff (PDF)

Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients

Journal of investigative dermatology, 2019-03, Vol.139 (3), p.725-728

2019

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(111)
Buchkapitel
(1)

Sprache

Englisch
(101)
Französisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

B Cell Modulation Strategies in Autoimmune Diseases: New Concepts

The DRESS Syndrome: A Literature Review

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

Clinical and biological activity of rituximab in the treatment of pemphigus

Autoimmune Pemphigus: Latest Advances and Emerging Therapies

Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen

Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus

Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients

B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses

Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction

CD158k/KIR3DL2 Is a New Phenotypic Marker of Sezary Cells: Relevance for the Diagnosis and Follow-Up of Sezary Syndrome

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference

Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice

Editorial: Skin Blistering Diseases

Reply

Reply

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Drug Reaction with Eosinophilia and Systemic Symptoms: an update on pathogenesis

IL-10 produced by activated human B cells regulates CD4⁺ T-cell activation in vitro

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response

Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features

Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients

Suchergebnisse filtern